Kliniska studier för Dermatit i Florida
5 studier för Dermatit söker deltagare vid platser i Florida.
Officiell studietext (engelska)
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Miami
- Novartis Investigative Site, St. Petersburg
RekryterarFas 2
Ålder 18 till 100 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06947993A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- Solutions Through Advanced Research, Jacksonville
RekryterarFas 3
Ålder 6 till 11 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06807268A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- AllerVie Clinical Research, Panama City
- GCP Research , Global Clinical Professionals, St. Petersburg
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- ABMED Clinical Research Corp., Cape Coral
- Skin Care Research, Hollywood
- Quality Care Clinical Research, Miami
- och 4 fler
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 28 aug. 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 19, Ocala
- Inmagene Site 4, Tampa
RekryterarFas 2
Ålder 18 till 74 · Alla kön · Uppdaterad 12 aug. 2026 · NCT07037901Från ClinicalTrials.gov, data hämtad 2 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.